AUSPEX PHARMACEUTICALS INC's ticker is ASPX and the CUSIP is 05211J102. A total of 89 filers reported holding AUSPEX PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $226,000 | – | 4,300 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 152,002 | $3,902,000 | 3.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,512,160 | $64,487,000 | 2.35% |
| Iguana Healthcare Management, LLC | 90,000 | $2,310,000 | 1.23% |
| WALL STREET ASSOCIATES | 435,000 | $11,166,000 | 1.15% |
| KNOTT DAVID M | 128,500 | $3,298,595,000 | 0.63% |
| Cormorant Asset Management, LP | 100,000 | $2,567,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 165,074 | $4,237,000 | 0.52% |
| Granite Point Capital Management, L.P. | 40,000 | $1,027,000 | 0.51% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 423,879 | $10,872,000 | 0.49% |
| Perceptive Advisors | 100,000 | $2,567,000 | 0.28% |